These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12815694)

  • 1. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
    Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
    Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE; Mostert JP; Oudkerk M; De Keyser J
    Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
    Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
    Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
    Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N
    Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
    Kirov II; Tal A; Babb JS; Herbert J; Gonen O
    Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
    Vrenken H; Barkhof F; Uitdehaag BM; Castelijns JA; Polman CH; Pouwels PJ
    Magn Reson Med; 2005 Feb; 53(2):256-66. PubMed ID: 15678547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
    Siger-Zajdel M; Selmaj K
    Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.
    Pelletier D; Nelson SJ; Grenier D; Lu Y; Genain C; Goodkin DE
    Magn Reson Imaging; 2002 Oct; 20(8):599-606. PubMed ID: 12467867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
    Szafirska M; Urbanik A; Róg T
    Przegl Lek; 2013; 70(5):328-34. PubMed ID: 23944105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
    Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
    PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
    Hannoun S; Bagory M; Durand-Dubief F; Ibarrola D; Comte JC; Confavreux C; Cotton F; Sappey-Marinier D
    PLoS One; 2012; 7(3):e32525. PubMed ID: 22479330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.